BNR

Burning Rock Biotech Limited

Price

$9.80

return (12m)

13.95%

p/e

-13.48

p/bv

1.51

DIVIDEND YIELD

0.00%

BNR price

Burning Rock Biotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BNR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.50%

3 months

-19.47%

1 year

13.95%

2 years

63.33%

5 years

-94.92%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BNR

Valuation

P/E

-13.48

Sector -4.26

Industry -4.26

P/BV

1.51

Sector 2.11

Industry 2.11

P/Revenue (PSR)

1.56

Sector 2.08

Industry 2.08

EV/EBITDA

-19.62

Sector -546.19

Industry -546.19

EV/EBIT

-19.62

Sector -37.31

Industry -37.31

P/EBITDA

-13.39

Sector -50.76

Industry -50.76

P/EBIT

-13.39

Sector -39.62

Industry -39.62

P/Total Assets

0.99

Sector 1.25

Industry 1.25

P/Net Current Assets

1.82

Sector -5.47

Industry -5.47

P/Working Capital

1.66

Sector -1.10

Industry -1.10

EPS

-0.77

Sector -1.94

Industry -1.94

BVPS

6.81

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

74.55%

Sector 38.90%

Industry 38.90%

EBITDA Margin

-15.96%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

-15.96%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-11.41%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-11.57%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.14

Sector 0.03

Industry 0.03

Profitability

ROE

-11.24%

Sector -61.50%

Industry -61.50%

ROA

-7.37%

Sector -63.85%

Industry -63.85%

ROIC

-31.65%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.05

Sector 2.89

Industry 2.89

Net Debt / EBITDA

25.78

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

25.78

Sector -10.24

Industry -10.24

Net Debt / Equity

-0.86

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.66

Sector 0.43

Industry 0.43

Liabilities/Assets

0.34

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-1.61%

Sector -

Industry -

5Y Earnings CAGR

-41.59%

Sector -

Industry -

Fundamentals BNR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNR Burning Rock Biotech Limited	$9.80	4.94%	0.00%	-13.48	1.51	-11.24%	-11.57%
JNJ Johnson & Johnson	$270.50	56.19%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.40	22.99%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$261.51	30.02%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-10.75%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$153.67	87.14%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$165.95	6.18%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.68	50.37%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$77.85	-48.70%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$823.41	40.89%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$442.24	55.97%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$108.20	49.84%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$894.24	32.40%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$549.81	41.36%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$237.95	65.02%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.40	5.29%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$220.77	58.47%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Burning Rock Biotech

Burning Rock Biotech Limited

Average Investor10 user rating

4.0 (1 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

938

Employees

Burning Rock Biotech Limited (United States) is listed on the Nasdaq and has a market capitalization of $113.52 million, with shareholders equity totaling $74.94 million.

The company employs approximately 938 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Burning Rock Biotech Limited reported $72.76 million in revenue, generating net income of $-8.42 million.

Key financial metrics include a P/E ratio of -13.48, a price-to-book (P/B) ratio of 1.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNR.

Market cap

$113.52 million

Net worth

$74.94 million

$74,940,000.00

Assets

$114.30 million

$114,300,000.00

Total Shares Outstanding

11.00 million

11,000,000

Average Daily Trading Volume

$15.21 Thousand

$15,208.76

Sector

Health Care

Industry

Biotechnology

BNR

BNR revenue and profits

Financial Results BNR

DRAG THE FRAME TO SEE MORE DATA

BNR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$894.24 32,08% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$237.95 63,39% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$270.50 57,89% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$261.51 29,51% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$153.67 87,85% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$165.95 6,34% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.40 24,07% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$894.24 32,08% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$237.95 63,39% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$270.50 57,89% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$261.51 29,51% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$153.67 87,85% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$165.95 6,34% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.40 24,07% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Burning Rock Biotech (BNR) today?

A cotação de Burning Rock Biotech (BNR) hoje está em US$ 9.80, com uma variação de 13.95% em relação ao último ano. A cotação de Burning Rock Biotech (BNR) iniciou o ano negociando na casa dos US$ 20.15 e hoje está em US$ 9.80. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Burning Rock Biotech (BNR) e dados de ações do Ibovespa e mercados internacionais.

Quando Burning Rock Biotech (BNR) paga dividendos?

Burning Rock Biotech (BNR) não distribuiu dividendos no último ano.

Is Burning Rock Biotech (BNR) a good investment?

Atualmente, Burning Rock Biotech (BNR) está cotada a US$ 9.80, com um P/L de -13.48, representando um desvio de -883% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 13.95 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 13.95%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Burning Rock Biotech (BNR) stock?

Investir em ações de Burning Rock Biotech (BNR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Burning Rock Biotech (BNR) yield today?

A rentabilidade de Burning Rock Biotech (BNR) foi de 9.50% no último mês, 13.95% no último ano e -94.92% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Burning Rock Biotech (BNR) hoje, o investimento total seria de US$ 980.00, com base na cotação atual de US$ 9.80.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,116.71
Em 5 anos: US$ 49.78
Em 10 anos: US$ 980.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BNR

Burning Rock Biotech Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BNR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BNR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Burning Rock Biotech

Burning Rock Biotech Limited

United States

12 years

2020

938

PROFIT X PRICE BNR

Financial Results BNR

BNR cash flow

Asset, Revenue and Profit Growth - BNR

BNR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions